Design a site like this with WordPress.com
Get started

A Combo offer to deal with Melanoma: Latest Development with Immune Checkpoint Inhibitors

Antibuddies

Modern Science has experienced huge breakthroughs over the last decades, one of the major ones being the discovery of immune checkpoints and their inhibitors. The checkpoint inhibitors revolutionized the stagnant field of cancer biology and were responsible for the rise of cancer immunotherapies. Immunotherapies command the immune system to destroy tumors by using antibodies against specific immunosuppressive surface receptors. Programmed cell death protein-1 (PD-1) is one such receptor expressed on T cells that interacts with programmed cell death ligand-1 (PD-L1) present on tumor cells, which leads to inactivation and subsequent anergy (absence of normal immune response) of T cells. Cytotoxic T lymphocyte-associated protein-4 (CTLA-4) is another receptor that is constitutively expressed on regulatory T cells and enhances its role by inhibiting the functions of other T cells and antigen-presenting cells, hence helping tumor growth. Monoclonal antibody treatments targeting these protein receptors are now widely used in clinics and have helpedā€¦

View original post 1,055 more words

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

Website Powered by WordPress.com.

Up ↑

%d bloggers like this: